O-mazing + Estradiol Vaginal Cream
Great Deal. Better Sex.
Menopause doesn’t mean saying goodbye to your sex life. Estrogen loss can cause dry vaginal skin, painful sex, and a dip in desire. Our Estradiol Vaginal Cream restores moisture and improves elasticity. Our O-mazing Cream stimulates lubrication and increases blood flow, leading to more fulfilling orgasms.
Together, they make sex feel good again!
$169.96
(90 days of treatment)
Individual Solutions
Estradiol Vaginal Cream
$39.99
O-mazing
$29.99
ONGOING, PERSONALIZED SUPPORT
All your sexual health questions answered
You’ll have unlimited access to your menopause-specialized doctor with your sexual health product subscription.
Science-backed ingredients
Estradiol
Sildenafil in O-mazing
80% of women will see improvement in vaginal symptoms within 4-12 weeks of starting treatment
Related Research
Laan E, van Lunsen RH, Everaerd W, Riley A, Scott E, Boolell M. The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women. J Womens Health Gend Based Med. 2002 May; 11(4):357-65. doi: 10.1089/152460902317585994. PMID: 12150498.
Faubion, Stephanie S., et al. “Management of Genitourinary Syndrome of Menopause in Women with or at High Risk for Breast Cancer.” Menopause, vol. 25, no. 6, June 2018, pp. 596–608, https://doi.org/10.1097/gme.0000000000001121.
Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008 Jul 23;300(4):395-404. doi: 10.1001/jama.300.4.395. PMID: 18647982.
North American Menopause Society. “The 2020 Genitourinary Syndrome of Menopause Position Statement of the North American Menopause Society.” Menopause, vol. 27, no. 9, Sept. 2020, pp. 976–992, https://doi.org/10.1097/gme.0000000000001609.
Schoen C, Bachmann G. Sildenafil citrate for female sexual arousal disorder: a future possibility? Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25. PMID: 19352396.
“The Role of Local Vaginal Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women.” Menopause, vol. 14, no. 3, May 2007, pp. 357–369, https://doi.org/10.1097/gme.0b013e31805170eb.
Bhupathiraju, Shilpa N., et al. “Vaginal Estrogen Use and Chronic Disease Risk in the Nurses' Health Study.” Menopause, vol. 26, no. 6, June 2019, pp. 603–610, https://doi.org/10.1097/gme.0000000000001284.